awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36172732-023E9DC8-B903-4F68-9EE8-E2FD12DB9274
Q36172732-023E9DC8-B903-4F68-9EE8-E2FD12DB9274
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36172732-023E9DC8-B903-4F68-9EE8-E2FD12DB9274
The effect of bevacizumab on human malignant melanoma cells with functional VEGF/VEGFR2 autocrine and intracrine signaling loops.
P2860
Q36172732-023E9DC8-B903-4F68-9EE8-E2FD12DB9274
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36172732-023E9DC8-B903-4F68-9EE8-E2FD12DB9274
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
35e2098275ca699bc775c910e86effaba848ff8a
P2860
FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer.